Heartflow, Inc. (NASDAQ:HTFL) Chief Financial Officer Vikram Verghese sold 3,587 shares of the company's common stock on November 9, 2026, at a price of $53.15 per share, for a total transaction value of $190,649. The sale was conducted under a Rule 10b5-1 trading plan that Verghese had adopted on June 4, 2026.
In a separate transaction on November 6, 2026, 2,009 shares of Heartflow common stock were withheld by the issuer to satisfy income tax withholding and remittance obligations. Those shares were valued at $105,271, based on a price of $52.40 per share, and were tied to the vesting and net settlement of previously reported restricted stock units.
Following these transactions, Verghese directly holds 149,587 shares of Heartflow common stock.
The insider sale occurs against a backdrop of significant share price appreciation. HTFL shares have climbed nearly 90% over the past six months and were last trading at $55.80. According to analysis, the stock appears overvalued relative to its fair value, placing it among the most overvalued stocks in the market.
In other recent developments, HeartFlow reported second-quarter 2026 earnings that showed a narrower-than-expected loss. The company posted adjusted earnings of negative $0.07 per share, compared with Wall Street's estimate of negative $0.19 per share. Revenue for the quarter increased 48% year over year to $64.1 million, driven by heightened demand for its coronary artery disease diagnostics.
Analyst reactions have been positive. Stifel raised its price target for HeartFlow shares to $45, citing the company's revenue performance, which exceeded both its own and consensus projections. Piper Sandler also increased its price target to $64 while maintaining an Overweight rating, highlighting HeartFlow's strong competitive position in the FFRct and plaque analysis market. Canaccord joined in by raising its price target to $56, based on an expanded survey of physicians using plaque analysis.
These developments reflect a positive outlook from analysts regarding HeartFlow's market position and growth potential in its specialized fields.